Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

- PMLiVE

Pfizer joins forces with IBM on immuno-oncology drug discovery

Engages the Watson supercomputer to accelerate research into new cancer therapies

- PMLiVE

PC: Are you Patient Centric or just Politically Correct?

Everyone in pharma is talking about patient centricity, but how is the drive received ‘on the ground’ among patients who are its focus? How is it unfolding and how far...

Roche Basel Switzerland

FDA delays verdict on Roche’s MS drug Ocrevus

Additional manufacturing data postpones US verdict until 28 March 2017

Novartis day

Novartis buys two firms in pre-Christmas shopping spree

Acquires eye disease specialist Encore Vision and NASH drug firm Conatus Pharma

- PMLiVE

Hanover Health opens market access practice

New practice will be led by director Jing Wang-Silvanto

Choose or lose

The divergence of business models demands brave choices

- PMLiVE

Teva Generics Europe appoints president and CEO

Promotes former UK general manager Richard Daniell

The Lucid Winter Summit 2016

Lucid Group put their skates on this year to celebrate an outstanding year’s performance at the Lucid Winter Summit at Somerset House, London.  Lucid Group enter their tenth year of...

Lucid Group Communications Limited

- PMLiVE

Novartis’ former UK government affairs head launches consultancy

Oxygen Strategy will offer pharma clients a 'fresh approach to strategy'

Biogen Idec building

Biogen elevates Vounatsos to top seat

US biotech’s CCO to succeed George Scangos on 6 January

- PMLiVE

FDA okays Clovis’ Lynparza rival rucaparib

Analysts predict Rubraca could become a $1.5bn-plus product by 2020

- PMLiVE

A New View

Creating value is key to the future of marketing

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links